Literature DB >> 32285325

Approach to Cyanotic Congenital Heart Disease in Children.

Manojkumar Rohit1, Palnivel Rajan2.   

Abstract

Early recognition and timely management of cyanotic congenital heart disease (CCHD) is necessary for good outcome. CCHD is an umbrella term encompassing many diseases with variable pathophysiology, which determines clinical presentation of CCHD. Conditions like total anomalous pulmonary venous connection (TAPVC) and transposition of great arteries (TGA) usually present in neonatal period. Tetralogy of Fallot (TOF) and related conditions present with squatting, cyanotic spells and silent chest with no evidence of congestive heart failure, whereas transposition physiology presents with congestive heart failure with cyanosis.

Entities:  

Keywords:  Cyanotic congenital heart disease; Tetralogy of Fallot; Transposition of great arteries

Mesh:

Year:  2020        PMID: 32285325     DOI: 10.1007/s12098-020-03274-3

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  3 in total

1.  Total anomalous pulmonary venous drainage: clinical and physiologic patterns.

Authors:  H B BURCHELL
Journal:  Proc Staff Meet Mayo Clin       Date:  1956-03-21

2.  The hyperoxic test in infants reinvestigated.

Authors:  B Bouferrache; S Filtchev; A Leke; Q Marbaix-Li; M Freville; C Gaultier
Journal:  Am J Respir Crit Care Med       Date:  2000-01       Impact factor: 21.405

Review 3.  An approach to diagnosis and management of cyanosis and tachypnea in term infants.

Authors:  Ponthenkandath Sasidharan
Journal:  Pediatr Clin North Am       Date:  2004-08       Impact factor: 3.278

  3 in total
  2 in total

1.  Treatment Evolution and the Impact of Pre-Surgical Predictors on Outcomes of Patients with Congenital Heart Disease.

Authors:  Maurice Zanini
Journal:  Arq Bras Cardiol       Date:  2022-02       Impact factor: 2.000

2.  Cardiopulmonary Exercise Testing in Repaired Tetralogy of Fallot: Multiparametric Overview and Correlation with Cardiac Magnetic Resonance and Physical Activity Level.

Authors:  Benedetta Leonardi; Federica Gentili; Marco Alfonso Perrone; Fabrizio Sollazzo; Lucia Cocomello; Stefani Silva Kikina; Rachel M Wald; Vincenzo Palmieri; Aurelio Secinaro; Maria Giulia Gagliardi; Attilio Parisi; Attilio Turchetta; Lorenzo Galletti; Massimiliano Bianco; Fabrizio Drago
Journal:  J Cardiovasc Dev Dis       Date:  2022-01-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.